Doctors Note Logo

Published on: 9/23/2026

Is the RSV vaccine yearly, like the flu shot?

No, the RSV vaccine is not given every year the way the flu shot is; current CDC guidance calls for a single lifetime dose for eligible adults, with no annual booster recommended at this time. Studies show protection lasting through roughly two or more RSV seasons, and eligibility depends on your age and risk factors, so timing matters more than repetition. There are several important details to consider, including who qualifies, when to get vaccinated, and how RSV protection differs for infants and pregnant people. See below to understand more.

If you are coughing, wheezing, or feeling feverish right now and wondering whether RSV, flu, or something else is behind it, a free, instant, online symptom check can help you sort out likely causes in minutes and point you toward the right next step, whether that is rest at home, a pharmacy visit, or prompt medical care.

Last reviewed for medical accuracy: 09/23/2025

answer background

Explanation

Is the RSV Vaccine Yearly, Like the Flu Shot?

Respiratory syncytial virus (RSV) can cause serious lung and airway infections, especially in babies, older adults and people with certain health conditions. If you’re wondering, “is RSV vaccine yearly?” you’re not alone. Here’s what you need to know about current recommendations—straightforward, without overstating risks or downplaying the facts.


What Is RSV?

  • RSV is a common virus that typically causes mild, cold-like symptoms.
  • In infants under 6 months, older adults (60+), and people with weakened immune systems or lung and heart conditions, RSV can lead to bronchiolitis or pneumonia.
  • RSV season often overlaps with flu season in fall and winter, but timing and intensity vary by region.

Who Can Get an RSV Vaccine?

Adults 60 and Older

  • The U.S. Food and Drug Administration (FDA) has approved RSV vaccines (e.g., Abrysvo, Arexvy) for adults 60 years and older.
  • A single dose can help reduce the risk of severe RSV illness, hospitalization and death.

Pregnant People

  • Vaccination between 32 and 36 weeks of pregnancy can pass protective antibodies to newborns, helping babies stay healthier in their first months of life.

High-Risk Groups

  • People aged 19–59 with certain chronic conditions (e.g., severe lung or heart disease) may also be eligible; check CDC guidelines or speak with your healthcare provider.

Is the RSV Vaccine Yearly?

Short Answer: No—at present, the RSV vaccine is not recommended on a yearly basis like the flu shot.

How RSV Vaccine Schedules Differ from Flu Shots

  • Flu shots: Recommended every year for most people six months and older, due to rapidly changing flu strains.
  • RSV vaccine: Currently authorized as a one-time dose for eligible adults and a single dose in pregnancy.
  • Booster doses: Not routinely recommended yet. Experts are monitoring immune responses and may update guidance as more data become available.

Why No Annual Dose (So Far)?

  1. Stable Target
    RSV strains evolve more slowly than flu viruses, reducing the need for seasonal formulation changes.
  2. Durable Immunity
    Early studies show a single RSV vaccine dose can provide protection for an entire season—potentially longer—though ongoing research will clarify exactly how long immunity lasts.
  3. Vaccine Development Stage
    RSV vaccines are newer to the adult market. As real-world data accumulate, public health agencies will reassess whether periodic revaccination is beneficial.

What to Watch for in Future Seasons

  • Regulatory Updates: The FDA and Centers for Disease Control and Prevention (CDC) review new evidence annually.
  • ACIP Recommendations: The Advisory Committee on Immunization Practices may revise schedules based on safety, effectiveness and the burden of RSV disease.
  • Next-Gen Vaccines: Research is underway on vaccines targeting multiple RSV strains or enhancing durability, which could influence booster timing.

Why Vaccination Matters

  • Reduces Severe Illness: Even if you’re generally healthy, RSV can cause hospitalization or complications in older age.
  • Protects Vulnerable Contacts: By cutting virus transmission, you help safeguard infants, immunocompromised loved ones and others at high risk.
  • Eases Healthcare Strain: Fewer RSV hospitalizations free up resources during peak respiratory-virus seasons.

Managing RSV Symptoms

If you or a family member develop cough, fever, wheezing or trouble breathing:

  1. Try at-home relief: Rest, fluids and over-the-counter fever reducers (ibuprofen or acetaminophen).
  2. Monitor closely: Note any worsening symptoms—especially rapid breathing, high fever, or bluish lips/fingertips.
  3. Check symptoms online: For a free, online symptom check, consider using the doctor‐approved Ubie Symptom Checker. It can help you decide when to seek medical care.

Key Takeaways

  • Is RSV vaccine yearly? No. Current guidelines call for a single RSV vaccine dose in eligible adults (60+) and one during pregnancy.
  • No routine booster: Annual shots are not standard, but recommendations may evolve.
  • Stay informed: Check CDC updates or ask your healthcare provider about RSV vaccines and any future booster advice.

Speak to a doctor about any serious or life-threatening symptoms. If you have questions about RSV, vaccination timing or ongoing health issues, your healthcare provider is the best source of personalized guidance.

(References)

  • * Wildenbeest JG, Lowe DM, Standing JF, Butler CC. Respiratory syncytial virus infections in adults: a narrative review. Lancet Respir Med. 2024 Oct;12(10):822-836. doi: 10.1016/S2213-2600(24)00255-8. Epub 2024 Sep 9. PMID: 39265602.

  • * GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Infect Dis. 2024 Sep;24(9):974-1002. doi: 10.1016/S1473-3099(24)00176-2. Epub 2024 Apr 15. PMID: 38636536; PMCID: PMC11339187.

  • * Terstappen J, Hak SF, Bhan A, Bogaert D, Bont LJ, Buchholz UJ, Clark AD, Cohen C, Dagan R, Feikin DR, Graham BS, Gupta A, Haldar P, Jalang'o R, Karron RA, Kragten L, Li Y, Löwensteyn YN, Munywoki PK, Njogu R, Osterhaus A, Pollard AJ, Nazario LR, Sande C, Satav AR, Srikantiah P, Stein RT, Thacker N, Thomas R, Bayona MT, Mazur NI. The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access. Lancet Infect Dis. 2024 Dec;24(12):e747-e761. doi: 10.1016/S1473-3099(24)00455-9. Epub 2024 Sep 23. PMID: 39326422; PMCID: PMC12311909.

  • * Scott J, Abers MS, Marwah HK, McCann NC, Meyerowitz EA, Richterman A, Fleming DF, Holmes EJ, Moat LE, Redepenning SG, Smith EA, Stoddart CJ, Sundaram ME, Ulrich AK, Alba C, Anderson CJ, Arpey MK, Borre E, Ladines-Lim J, Mehr AJ, Rich K, Watts C, Basta NE, Jarolimova J, Walensky RP, Dugdale CM. Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026. N Engl J Med. 2025 Dec 4;393(22):2221-2242. doi: 10.1056/NEJMsa2514268. Epub 2025 Oct 29. PMID: 41160817.

  • * Agac A, Kolbe SM, Ludlow M, Osterhaus ADME, Meineke R, Rimmelzwaan GF. Host Responses to Respiratory Syncytial Virus Infection. Viruses. 2023 Sep 26;15(10). doi: 10.3390/v15101999. Epub 2023 Sep 26. PMID: 37896776; PMCID: PMC10611157.

  • * Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005 Apr 28;352(17):1749-59. doi: 10.1056/NEJMoa043951. PMID: 15858184.

  • * Surie D, Self WH, Yuengling KA, Lauring AS, Zhu Y, Safdar B, Ginde AA, Simon SJ, Peltan ID, Brown SM, Gaglani M, Ghamande S, Columbus C, Mohr NM, Gibbs KW, Hager DN, Prekker M, Gong MN, Mohamed A, Johnson NJ, Steingrub JS, Khan A, Duggal A, Gordon AJ, Qadir N, Chang SY, Mallow C, Felzer JR, Kwon JH, Exline MC, Vaughn IA, Ramesh M, Papalambros L, Mosier JM, Harris ES, Baughman A, Cornelison SA, Blair PW, Johnson CA, Lewis NM, Ellington S, Grijalva CG, Talbot HK, Casey JD, Halasa N, Chappell JD, Rutkowski RE, Ma KC, Dawood FS, Investigating Respiratory Viruses in the Acutely Ill (IVY) Network. RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons. JAMA. 2025 Oct 28;334(16):1442-1451. doi: 10.1001/jama.2025.15896. PMID: 40884491; PMCID: PMC12398767.

  • * Foley DA, Phuong LK. RSV: an update on prevention and management. Aust Prescr. 2025 Apr;48(2):34-39. doi: 10.18773/austprescr.2025.018. PMID: 40343137; PMCID: PMC12055488.

  • * Ison MG, Papi A, Athan E, Feldman RG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Verheust C, Dezutter N, Gruselle O, Fissette L, David MP, Kostanyan L, Hulstrøm V, Olivier A, Van der Wielen M, Descamps D, AReSVi-006 Study Group. Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons. Clin Infect Dis. 2024 Jun 14;78(6):1732-1744. doi: 10.1093/cid/ciae010. PMID: 38253338; PMCID: PMC11175669.

  • * Woodruff RC, Melgar M, Pham H, Sperling LS, Loustalot F, Kirley PD, Austin E, Yousey-Hindes K, Openo KP, Ryan P, Brown C, Lynfield R, Davis SS, Barney G, Tesini B, Sutton M, Talbot HK, Zahid H, Kim L, Havers FP, Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET). Acute Cardiac Events in Hospitalized Older Adults With Respiratory Syncytial Virus Infection. JAMA Intern Med. 2024 Jun 1;184(6):602-611. doi: 10.1001/jamainternmed.2024.0212. PMID: 38619857; PMCID: PMC11019447.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.